CK Life Sciences (00775) Issues Monthly Return for February 2026
Bulletin Express
Mar 03
CK Life Sciences Int'l., (Holdings) Inc. (stock code: 00775) released its monthly return on movements in securities for the period ended 28 February 2026. Authorized share capital remained at 15.00 billion ordinary shares with a par value of HKD 0.10 each, totaling HKD 1.50 billion.
Issued share capital stood unchanged at 9.61 billion ordinary shares, while the company confirmed compliance with its prescribed public float threshold of 25%. No changes in treasury shares or other equity movements were recorded during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.